JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model

Laszlo F. Locskai, Shayleen Ghassemi, Samantha A.W. Tan, Melissa J. Kinley, W. Ted Allison

Open source

DOI
10.1016/j.expneurol.2026.116014
Published
2027-01
Container
Experimental Neurology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.expneurol.2026.116014,
  title = {JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model},
  author = {Laszlo F. Locskai and Shayleen Ghassemi and Samantha A.W. Tan and Melissa J. Kinley and W. Ted Allison},
  year = {2027},
  journal = {Experimental Neurology},
  doi = {10.1016/j.expneurol.2026.116014},
  url = {https://doi.org/10.1016/j.expneurol.2026.116014}
}

RIS

TY  - JOUR
TI  - JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model
AU  - Laszlo F. Locskai
AU  - Shayleen Ghassemi
AU  - Samantha A.W. Tan
AU  - Melissa J. Kinley
AU  - W. Ted Allison
PY  - 2027
JO  - Experimental Neurology
DO  - 10.1016/j.expneurol.2026.116014
UR  - https://doi.org/10.1016/j.expneurol.2026.116014
ER  - 

APA

Locskai, L. F., Ghassemi, S., Tan, S. A., Kinley, M. J., & Allison, W. T. (2027). JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2026.116014

Source records